Tevogen (TVGN) Profit After Tax (2022 - 2026)

Tevogen Bio Holdings (TVGN) has 5 years of Profit After Tax data on file, last reported at -$5.6 million in Q1 2026.

• Quarterly Profit After Tax rose 46.48% year-over-year to -$5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$21.1 million (up 40.44% YoY) and the FY2025 annual result came in at -$26.3 million, down 155.75% from the prior year.
• Profit After Tax slipped to -$5.6 million in Q1 2026, from -$4.3 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $11.3 million in Q1 2024 to a low of -$30.8 million in Q1 2023.
• A 5-year average of -$6.0 million and a median of -$5.5 million in 2025 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2023 — Profit After Tax tumbled 118247.48% — and 2024, when it surged 136.63%.
• Tracing TVGN's Profit After Tax over 5 years: stood at $2.6 million in 2022, then tumbled by 238.93% to -$3.6 million in 2023, then plunged by 159.05% to -$9.4 million in 2024, then soared by 54.64% to -$4.3 million in 2025, then sank by 31.72% to -$5.6 million in 2026.
• The last three Profit After Tax figures came in at -$5.6 million (Q1 2026), -$4.3 million (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.